Clinical trial
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
NCT00365261 · University of California, San Diego, Other · Completed
Key facts
| NCT number | NCT00365261 |
|---|---|
| Title | Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer |
| Official title | Effect of Eszopiclone (Lunesta) on Sleep Disturbance and Pain in Cancer |
| Lead sponsor | University of California, San Diego, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Drug |
| Interventions | Eszopiclone, Placebo |
| Enrollment | 45 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Aug 17, 2006 |
| Last update posted | Jul 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: